About this episode
A vaccine which has shown in a clinical trial to be 90% effective against Covid 19 has been widely welcomed. But what does it mean and how was it worked out? Although experts and politicians urge caution, how excited can we be about the results of this trial of the vaccine developed by Pfizer and BioNTech? Tim Harford explores what we know about this new vaccine candidate with Jennifer Rogers, vice president of the Royal Statistical Society in the UK, and she also works for Phastar, a consultancy which specialises in analysing clinical trials. Presenter: Tim Harford Producer: Charlotte McDonald
Get every episode summarized
Each time More or Less publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from More or Less
Why are so many ex-prisoners being sent back to prison?
More or Less
Is every card shuffle unique?
More or Less
Bonus podcast: Norman Numbers
More or Less
Do Germans really take 19.5 days of sick leave per year?
More or Less